Entera Bio Ltd.
ENTX
$2.17
-$0.12-5.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 95.24% | -26.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 95.24% | -26.32% | |||
| Cost of Revenue | 95.24% | -12.50% | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | -26.42% | 41.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -21.03% | 37.85% | |||
| Operating Income | 22.64% | -39.54% | |||
| Income Before Tax | 22.41% | -40.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.95% | -40.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.95% | -40.84% | |||
| EBIT | 22.64% | -39.54% | |||
| EBITDA | 22.72% | -39.74% | |||
| EPS Basic | 24.91% | -38.93% | |||
| Normalized Basic EPS | 25.30% | -39.06% | |||
| EPS Diluted | 24.91% | -38.93% | |||
| Normalized Diluted EPS | 25.30% | -39.06% | |||
| Average Basic Shares Outstanding | 3.89% | 1.49% | |||
| Average Diluted Shares Outstanding | 3.89% | 1.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||